BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in RANI — Rani Therapeutics Holdings, Inc.

CIK 1107261 HOUSTON, TX

Position in RANI

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$87,020

+$2,863 QoQ

Shares Held

114,500

0.0% QoQ

Ownership

0.082%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 67 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. RANI ranks #97 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$87,020	114,500	0.0%	Shares	Sole	2026-08-14
2026-03-31	$84,157	114,500	0.0%	Shares	Sole	2026-05-15
2025-12-31	$154,575	114,500	+146.2%	Shares	Sole	2026-02-17
2025-06-30	$23,901	46,500	0.0%	Shares	Sole	2025-08-14
2025-03-31	$58,590	46,500	-17.7%	Shares	Sole	2025-05-15
2024-12-31	$77,405	56,500	-21.0%	Shares	Sole	2025-02-14
2024-09-30	$154,440	71,500	0.0%	Shares	Sole	2024-11-14
2024-06-30	$271,700	71,500	+38.8%	Shares	Sole	2024-08-14
2024-03-31	$160,165	51,500	0.0%	Shares	Sole	2024-05-15
2023-12-31	$170,980	51,500	0.0%	Shares	Sole	2024-02-14
2023-09-30	$112,012	51,500	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.